Skip to content
  • 01/16/2021 6:49 AM
Standard Tribune
  • Home
  • About Us
  • Contacts
  • Privacy Policy

: Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness

Oct 12, 2020

A woman receives an injection during phase 3 testing for the Johnson & Johnson vaccine candidate.


Johnson & Johnson via AP

Johnson & Johnson has paused clinical trials for its COVID-19 vaccine candidate after an unexplained illness by a participant

The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and enrollment has been halted, citing  “an unexplained illness in a study participant.”

Let’s block ads! (Why?)

Post navigation

Wisconsin says Foxconn short of 2019 jobs pledge, misses out on tax credits
Where Should I Retire?: This newcomer is the best place to live — but you probably don’t want to retire there

Related Post

Uganda’s Museveni heads for election win, rival alleges fraud

Jan 16, 2021

Myanmar police scuffle with nationalist monk’s followers

Jan 16, 2021

In visit to Central African Republic, French general says situation not same as 2013

Jan 16, 2021
Recent Posts
  • Uganda’s Museveni heads for election win, rival alleges fraud
  • Myanmar police scuffle with nationalist monk’s followers
  • In visit to Central African Republic, French general says situation not same as 2013
  • DeChambeau says dizzy spells at Masters due to brain overworking
  • U.S. to carry out 13th and final execution under Trump administration
Archives
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
Sponsors
Life Token

You missed

Uncategorized

Uganda’s Museveni heads for election win, rival alleges fraud

Jan 16, 2021
Uncategorized

Myanmar police scuffle with nationalist monk’s followers

Jan 16, 2021
Uncategorized

In visit to Central African Republic, French general says situation not same as 2013

Jan 16, 2021
Uncategorized

DeChambeau says dizzy spells at Masters due to brain overworking

Jan 15, 2021
Standard Tribune

Proudly powered by WordPress | Theme: Newsup by Themeansar.

  • Home
  • About Us
  • Contacts
  • Privacy Policy